

2025 marked a turning point in traumatic brain injury (TBI) research, with studies now showing that TBI is a chronic condition characterised by prolonged biomarker elevations and long-term comorbidities, fundamentally shifting clinical management from acute intervention to lifelong monitoring and care. A new TBI classification framework was developed that captures the heterogeneity of TBI, which will allow for personalised treatment and targeted clinical trials. In parallel, emerging therapeutic approaches offer renewed hope for better outcomes.
Neurology
|22nd Dec, 2025
|Journal of the American Medical Association
Neurology
|18th Dec, 2025
|Journal of the American Medical Association
Neurology
|17th Dec, 2025
|Journal of the American Medical Association
Neurology
|15th Jan, 2026
|The Lancet
Neurology
|15th Dec, 2025
|Journal of the American Medical Association
Neurology
|15th Jan, 2026
|Journal of the American Medical Association
Neurology
|15th Jan, 2026
|Journal of the American Medical Association